Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 221

Similar articles for PubMed (Select 23402593)

1.

Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.

Lee GY, Qian WP, Wang L, Wang YA, Staley CA, Satpathy M, Nie S, Mao H, Yang L.

ACS Nano. 2013 Mar 26;7(3):2078-89. doi: 10.1021/nn3043463. Epub 2013 Mar 12.

2.

MO-FG-BRA-07: Theranostic Gadolinium-Based AGuIX Nanoparticles for MRI-Guided Radiation Therapy.

Detappe A, Rottmann J, Kunjachan S, Tillement O, Berbeco R.

Med Phys. 2015 Jun;42(6):3566. doi: 10.1118/1.4925411.

PMID:
26128714
3.

Natural polysaccharide functionalized gold nanoparticles as biocompatible drug delivery carrier.

Pooja D, Panyaram S, Kulhari H, Reddy B, Rachamalla SS, Sistla R.

Int J Biol Macromol. 2015 Jun 18;80:48-56. doi: 10.1016/j.ijbiomac.2015.06.022. [Epub ahead of print]

PMID:
26093321
4.

MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies.

Ren L, Chen S, Li H, Zhang Z, Ye C, Liu M, Zhou X.

Nanoscale. 2015 May 29. [Epub ahead of print]

PMID:
26022345
5.

Targeted drug delivery systems for pancreatic cancer.

Khare V, Alam N, Saneja A, Dubey RD, Gupta PN.

J Biomed Nanotechnol. 2014 Dec;10(12):3462-82. Review.

PMID:
26000366
6.
7.

Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.

Lin J, Li Y, Li Y, Wu H, Yu F, Zhou S, Xie L, Luo F, Lin C, Hou Z.

ACS Appl Mater Interfaces. 2015 Jun 10;7(22):11908-20. doi: 10.1021/acsami.5b01685. Epub 2015 May 28.

PMID:
25978458
8.

A multifunctional peptide for targeted imaging and chemotherapy for nasopharyngeal and breast cancers.

Hsiao JK, Wu HC, Liu HM, Yu A, Lin CT.

Nanomedicine. 2015 Apr 14. pii: S1549-9634(15)00085-4. doi: 10.1016/j.nano.2015.03.011. [Epub ahead of print]

PMID:
25881740
9.

Antibody-mediated targeting of iron oxide nanoparticles to the folate receptor alpha increases tumor cell association in vitro and in vivo.

Ndong C, Toraya-Brown S, Kekalo K, Baker I, Gerngross TU, Fiering SN, Griswold KE.

Int J Nanomedicine. 2015 Apr 1;10:2595-617. doi: 10.2147/IJN.S79367. eCollection 2015.

10.

Glucose-coated superparamagnetic iron oxide nanoparticles prepared by metal vapour synthesis are electively internalized in a pancreatic adenocarcinoma cell line expressing GLUT1 transporter.

Barbaro D, Di Bari L, Gandin V, Evangelisti C, Vitulli G, Schiavi E, Marzano C, Ferretti AM, Salvadori P.

PLoS One. 2015 Apr 15;10(4):e0123159. doi: 10.1371/journal.pone.0123159. eCollection 2015.

11.

Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.

Kaluzova M, Bouras A, Machaidze R, Hadjipanayis CG.

Oncotarget. 2015 Apr 20;6(11):8788-806.

12.

GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells.

Wang L, An Y, Yuan C, Zhang H, Liang C, Ding F, Gao Q, Zhang D.

Int J Nanomedicine. 2015 Mar 30;10:2507-19. doi: 10.2147/IJN.S77642. eCollection 2015.

13.

Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells.

Kempen PJ, Greasley S, Parker KA, Campbell JL, Chang HY, Jones JR, Sinclair R, Gambhir SS, Jokerst JV.

Theranostics. 2015 Mar 1;5(6):631-42. doi: 10.7150/thno.11389. eCollection 2015.

14.

Design and Function of Engineered Protein Nanocages as a Drug Delivery System for Targeting Pancreatic Cancer Cells via Neuropilin-1.

Murata M, Narahara S, Kawano T, Hamano N, Piao JS, Kang JH, Ohuchida K, Murakami T, Hashizume M.

Mol Pharm. 2015 May 4;12(5):1422-30. doi: 10.1021/mp5007129. Epub 2015 Apr 10.

PMID:
25811429
15.

Magnetic nanoparticles and their applications in image-guided drug delivery.

Yu MK, Park J, Jon S.

Drug Deliv Transl Res. 2012 Feb;2(1):3-21. doi: 10.1007/s13346-011-0049-8.

PMID:
25786597
16.
17.

Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.

Meng H, Wang M, Liu H, Liu X, Situ A, Wu B, Ji Z, Chang CH, Nel AE.

ACS Nano. 2015 Apr 28;9(4):3540-57. doi: 10.1021/acsnano.5b00510. Epub 2015 Mar 31.

18.

Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer.

Wang XB, Zhou HY.

Biomed Pharmacother. 2015 Mar;70:123-8. doi: 10.1016/j.biopha.2015.01.008. Epub 2015 Jan 12.

PMID:
25776490
19.

Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules.

Fang Y, Du F, Xu Y, Meng H, Huang J, Zhang X, Lu W, Liu S, Yu J.

Colloids Surf B Biointerfaces. 2015 Apr 1;128:357-62. doi: 10.1016/j.colsurfb.2015.02.028. Epub 2015 Feb 21.

PMID:
25746328
20.

Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates.

Galbiati E, Cassani M, Verderio P, Martegani E, Colombo M, Tortora P, Mazzucchelli S, Prosperi D.

Bioconjug Chem. 2015 Apr 15;26(4):680-9. doi: 10.1021/acs.bioconjchem.5b00005. Epub 2015 Mar 13.

PMID:
25741889
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk